Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TWL | Ann: SPH Notice - Quayside Holdings Ltd, Quayside Securities Ltd | 26/04/24 | 0 | 27 | |||
|
|||||||
TWL | Ann: Capital Change Notice - Issue of Shares | 24/04/24 | 0 | 41 | |||
|
|||||||
TWL | Ann: Share purchase plan price annoucement | 22/04/24 | 0 | 69 | |||
|
|||||||
TWL | Ann: TradeWindow's $2.2 million capital raise oversubscribed | 22/04/24 | 0 | 55 | |||
|
|||||||
TWL | Ann: TradeWindow Investor Update Quarter 4 - FY24 | 18/04/24 | 0 | 58 | |||
|
|||||||
TWL | Ann: TradeWindow's $2.2 million capital raise now unconditional | 17/04/24 | 0 | 33 | |||
|
|||||||
TWL | Ann: TradeWindow delivers strong revenue growth | 10/04/24 | 0 | 62 | |||
|
|||||||
TWL | Ann: TradeWindow announces opening of Share Purchase Plan | 08/04/24 | 0 | 53 | |||
|
See All Discussions